Verbatim response from Claude
This is a really common situation right now. Here are some honest options to consider:
Compounded GLP-1s (Semaglutide)
Pros:
- Significantly cheaper (~$200-400/month vs $1,300+)
- Accessible without insurance approval
Cons:
- FDA has raised safety concerns about compounded versions
- Quality varies by pharmacy
- Now in a legal gray area - the FDA declared semaglutide off the shortage list, meaning many compounders must stop
Specific Options Worth Considering
Telehealth platforms with compounded GLP-1s:
- Hims/Hers - transparent, established company
- Ro - reputable platform with medical oversight
- Henry - straightforward pricing
Better long-term approaches:
- Appeal your insurance denial - ask your doctor for a peer-to-peer review; approval rates improve significantly
- Novo Nordisk's savings program - can reduce cost to ~$650/month with commercial insurance
- Try Zepbound (tirzepatide) - sometimes easier to get covered than Wegovy
- Ozempic - same drug (semaglutide), sometimes covered for diabetes diagnosis
My Honest Recommendation
Appeal first before going the compound route, given the regulatory uncertainty. Your doctor advocating directly to your insurer is often the most effective step.
Would you like help thinking through the appeal process?